Disparities in Linking Children to Hepatitis C Care Uncovered
Recent research highlights significant disparities in the process of linking children diagnosed with hepatitis C virus (HCV) to appropriate care. The study, published online April 18 in Pediatrics, analyzed the care cascade among children born from 2000 to 2018 who received an HCV diagnosis before age 18. Findings revealed that only 32% of these children were connected to HCV care, and merely 12% received direct-acting antivirals (DAAs), a modern treatment option.
The analysis showed notable racial and ethnic disparities: Hispanic/Latinx children and white children had twice and three times the odds, respectively, of being linked to care compared to Black children. This indicates ongoing inequities in access and treatment within the pediatric HCV care pathway.
Researchers Megan Rose Curtis, M.D., from Washington University in St. Louis, and colleagues emphasized that these gaps disproportionately affect marginalized populations. They suggest that improving linkage programs—such as patient navigation, training primary care providers to treat adolescents with HCV, and offering treatment immediately upon diagnosis in nonclinical settings—could help bridge these disparities.
Addressing these gaps is essential for reducing the burden of hepatitis C among children and ensuring equitable healthcare delivery. The study underscores the need for targeted interventions to improve the care cascade for vulnerable groups.
Source: [https://medicalxpress.com/news/2025-04-disparities-linkage-children-hepatitis.html]
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Strategies in Pediatric Brain Cancer Treatment: Focused Therapies and Advanced Delivery Techniques
Virginia Tech researchers are developing precise targeted therapies and advanced delivery techniques to improve treatment outcomes for pediatric brain cancer, especially glioblastoma. Using focused ultrasound to enhance drug delivery and targeting specific proteins like KAT6A may revolutionize future therapies.
Advances in Molecular Approaches for Treating Angelman Syndrome
A new review explores recent advances in molecular strategies for treating Angelman syndrome, focusing on gene reactivation techniques and targeting disrupted cellular pathways to move beyond symptom management.
U.S. Meat Supply Tested by Olympic Anti-Doping Laboratory for Performance-Enhancing Substances
UCLA athletes' anti-doping testing methods are now used to analyze U.S. meat for performance-enhancing residues. The study confirms that beef, pork, and chicken typically contain safe levels of growth-promoting agents, supporting current regulatory practices.
